ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
value factor · long-only model fund

Foundry Consumer Cyclical Enterprise Multiple Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FENCHYPOTHETICAL MODEL
Since ’99
−56%
Expense Ratio
0.45%
placeholder
Holdings
55
cap-weighted
Inception
Jun 2020
placeholder
Full Sharpe
-0.03
Ann. Return (LS)
-0.6%
Ann. Volatility
21.8%
Max Drawdown
-92.9%
Test Sharpe ’19–26
-0.22
Test FF5 α (ann.)
-9.7%
vs Fama-French 5
Test FF5 α t-stat
-1.15
not significant
Monthly turnover
13%
of the long leg, per rebalance
Cumulative return (LS)
-56%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.51
what this fund holds
Long leg ann. return
13.2%
buyable, long-only
Long-short Sharpe
-0.03
requires shorting
Bottom bucket ann. return
13.8%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

55 of 55 · 100.0% of book
TickerCompanySectorMarket capWeight
1BBY
BEST BUY CO INCConsumer Cyclical$18.00B
11.43%
2LULU
LULULEMON ATHLETICA INCConsumer Cyclical$12.61B
8.01%
3ALV
AUTOLIV INCConsumer Cyclical$8.81B
5.59%
4GAP
GAP INCConsumer Cyclical$7.33B
4.65%
5LEA
LEAR CORPConsumer Cyclical$7.10B
4.51%
6MHK
MOHAWK INDUSTRIES INCConsumer Cyclical$6.80B
4.32%
7BYD
BOYD GAMING CORPConsumer Cyclical$6.52B
4.14%
8URBN
URBAN OUTFITTERS INCConsumer Cyclical$6.25B
3.97%
9M
MACY'S INCConsumer Cyclical$6.23B
3.96%
10SON
SONOCO PRODUCTS COConsumer Cyclical$5.59B
3.55%
11HRB
H&R BLOCK INCConsumer Cyclical$5.33B
3.39%
12ANF
ABERCROMBIE & FITCH COConsumer Cyclical$4.23B
2.69%
13BBWI
BATH & BODY WORKS INCConsumer Cyclical$4.21B
2.67%
14MAT
MATTEL INCConsumer Cyclical$4.15B
2.63%
15THO
THOR INDUSTRIES INCConsumer Cyclical$3.97B
2.52%
16SIG
SIGNET JEWELERS LTDConsumer Cyclical$3.60B
2.29%
17PVH
PVH CORPConsumer Cyclical$3.60B
2.29%
18GPK
GRAPHIC PACKAGING HOLDING COConsumer Cyclical$3.20B
2.03%
19GRBK
GREEN BRICK PARTNERS INCConsumer Cyclical$3.14B
1.99%
20ASO
ACADEMY SPORTS & OUTDOORS INCConsumer Cyclical$3.00B
1.91%
21DAN
DANA INCConsumer Cyclical$2.87B
1.83%
22AEO
AMERICAN EAGLE OUTFITTERS INCConsumer Cyclical$2.85B
1.81%
23VC
VISTEON CORPConsumer Cyclical$2.80B
1.78%
24WLY
JOHN WILEY & SONS INCConsumer Cyclical$2.59B
1.64%
25KSS
KOHLS CORPConsumer Cyclical$1.96B
1.25%
26LZB
LA-Z-BOY INCConsumer Cyclical$1.59B
1.01%
27ADNT
ADIENT PLCConsumer Cyclical$1.55B
0.99%
28LEG
LEGGETT & PLATT INCConsumer Cyclical$1.50B
0.96%
29GIII
G III APPAREL GROUP LTDConsumer Cyclical$1.49B
0.95%
30MLKN
MILLERKNOLL INCConsumer Cyclical$1.49B
0.95%
31TRS
TRIMAS CORPConsumer Cyclical$1.46B
0.93%
32SBH
SALLY BEAUTY HOLDINGS INCConsumer Cyclical$1.42B
0.90%
33TDAY
USA TODAY CO INCConsumer Cyclical$1.25B
0.79%
34ARHS
ARHAUS INCConsumer Cyclical$1.09B
0.69%
35SCHL
SCHOLASTIC CORPConsumer Cyclical$1.02B
0.65%
36ACEL
ACCEL ENTERTAINMENT INCConsumer Cyclical$989M
0.63%
37CARS
CARSCOM INCConsumer Cyclical$670M
0.43%
38ETD
ETHAN ALLEN INTERIORS INCConsumer Cyclical$580M
0.37%
39CTRN
CITI TRENDS INCConsumer Cyclical$535M
0.34%
40BBW
BUILD-A-BEAR WORKSHOP INCConsumer Cyclical$428M
0.27%
41SHOE
SHOE CARNIVAL INCConsumer Cyclical$393M
0.25%
42FLXS
FLEXSTEEL INDUSTRIES INCConsumer Cyclical$391M
0.25%
43WEYS
WEYCO GROUP INCConsumer Cyclical$374M
0.24%
44LE
LANDS' END INCConsumer Cyclical$357M
0.23%
45STRT
STRATTEC SECURITY CORPConsumer Cyclical$344M
0.22%
46ZUMZ
ZUMIEZ INCConsumer Cyclical$315M
0.20%
47HBB
HAMILTON BEACH BRANDS HOLDING COConsumer Cyclical$313M
0.20%
48MPAA
MOTORCAR PARTS OF AMERICA INCConsumer Cyclical$265M
0.17%
49JILL
JJILL INCConsumer Cyclical$248M
0.16%
50INSE
INSPIRED ENTERTAINMENT INCConsumer Cyclical$174M
0.11%
51UFI
UNIFI INCConsumer Cyclical$118M
0.07%
52MED
MEDIFAST INCConsumer Cyclical$114M
0.07%
53KEQU
KEWAUNEE SCIENTIFIC CORPConsumer Cyclical$109M
0.07%
54BDL
FLANIGANS ENTERPRISES INCConsumer Cyclical$76M
0.05%
55RGS
REGIS CORPConsumer Cyclical$74M
0.05%

Full long-leg book as of July 2026 · cap-weighted · total market cap $157.49B. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

1 sectors
Consumer Cyclical
100.0%

Portfolio Style

Size × value map of the long-leg book

55 classified
Value
Blend
Growth
Large
Mid
Small
29%6
21%3
·
34%18
7%3
2%2
3%14
2%6
1%2

Share of long-leg capital by market cap × book-to-market, using terciles of the 310-name universe at July 2026. Rows: Large ≥ $5.9B, Small < $1.3B. Columns: Value ≥ 0.62, Growth < 0.38 B/M. The dot marks the capital-weighted centroid of the book — 72% toward Large, 18% toward Growth. Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt72% → Large
SmallLarge
Value ↔ growth tilt18% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 55 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
5
Failed
1
Not tested
1
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

1 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    36.5 days
    Margin
    -29.5 days
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 55 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.7 (95% CI 1.3-2.3)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
16.7%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.73x
within
parametric
1.65x
within
cornish fisher
1.91x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2011
Before publication (pre-2011)
0.41
Sharpe · 7.9% p.a.
January 1999December 2011 · 156 mo
Since publication
-0.35
Sharpe · -8.1% p.a.
January 2012July 2026 · 175 mo
Change in Sharpe−0.75the return reversed sign — the published edge now runs the other way

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
42%
11 of 26 3-year windows made money
Worst window
-1.60
Sharpe, January 2018 – December 2020
January 1999July 2026
Median Sharpe
-0.26
Dispersion
0.89
Best window
2.08

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.21.7%10.2%
3 yearsp.a.15.0%-2.0%
5 yearsp.a.11.4%2.7%
10 yearsp.a.10.3%-10.9%
Since inceptionp.a.10.3%-2.9%
Calendar years
YearLong legLong-short
20267 mo6.7%17.2%
202511.3%-0.2%
202415.8%-24.6%
202354.3%1.5%
2022-21.1%36.9%
202132.2%12.6%
2020-2.7%-61.1%
20197.3%-14.7%
2018-14.0%-28.9%
201723.4%-11.7%
201613.3%9.2%
2015-14.9%-37.1%
20148.7%13.6%
201337.1%-8.3%
201223.4%-2.2%
2011-14.4%-13.6%
201022.7%-19.1%
200968.7%-0.0%
2008-50.1%20.4%
2007-27.8%-29.1%
20064.3%-4.8%
20055.3%14.1%
200425.3%-2.8%
200362.4%15.1%
200216.7%51.4%
200150.9%46.0%
2000-0.9%23.9%
199936.7%11.0%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FENC
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.45% (placeholder)
Inception2020-06-02 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$157.49B

Methodology

The Foundry Consumer Cyclical Enterprise Multiple Factor ETF tracks a rules-based model that ranks Consumer Cyclical common stocks each month by a Enterprise Multiple signal and holds the top quintile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.